Earlier studies have linked glucosamine supplements to a lower dementia risk in cognitively healthy adults. Our findings do not contradict those reports but qualify them. While glucosamine appears ...
A woman with advanced Alzheimer's reportedly showed significant brain function improvements after taking psilocybin mushrooms ...
The number of patients living with neurodegenerative diseases that affect movement is rising steadily. Yet a large-scale ...
POTOMAC, MD / ACCESS Newswire / June 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a ...
Natalie Morales, 54, doesn't have dementia. But her experience caring for a family member with Alzheimer's has stuck with her ...
Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today ...
Researchers have identified a new Alzheimer’s target and created an experimental compound that blocks a damaging process ...
Following the sustained success of the initial dose, the woman received a three-gram dose a month later, resulting in ...
"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the ...
The turning point was when one of Willis' neurologists revealed an alarming statistic about caregiver health: she shared ...
Biogen has agreed to pay $18.9 million to resolve a lawsuit alleging that it misled investors about the commercial readiness ...
A flurry of big-money donations is strengthening South Florida’s health systems, a trend that will significantly benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results